Association of Chronic Kidney Disease with Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus: An Observational Cross-sectional Study in Hangzhou, China
- PMID: 28051024
- PMCID: PMC5221113
- DOI: 10.4103/0366-6999.196564
Association of Chronic Kidney Disease with Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus: An Observational Cross-sectional Study in Hangzhou, China
Abstract
Background: Chronic kidney disease (CKD) is an independent risk factor for cardiovascular disease (CVD). However, the association between CKD and CVD risk in patients with type 2 diabetes mellitus (T2DM) in China has not yet been well investigated. This study aimed to determine the association of CKD with the risks of coronary heart disease (CHD) and stroke in a Chinese population with T2DM.
Methods: A total of 1401 inpatients with T2DM at the Second Affiliated Hospital of Zhejiang University School of Medicine between April 2008 and November 2013 were included in this study. The CKD-Epidemiology Collaboration equation for Asians was used to classify CKD. The UK Prospective Diabetes Study risk engine was used to estimate the risks of CHD and stroke.
Results: CHD risk was significantly increased with CKD stage (20.1%, 24.8%, and 34.3% in T2DM patients with no CKD, CKD Stage 1-2, and Stage 3-5, respectively; P < 0.001 for all). The stroke risk was also increased with CKD stage (8.6%, 12.7%, and 25.4% in T2DM patients with no CKD, CKD Stage 1-2, and Stage 3-5, respectively; P < 0.001 for all). Compared with no-CKD group, the odds ratios (OR s) for high CHD risk were 1.7 (P < 0.001) in the CKD Stage 1-2 group and 3.5 (P < 0.001) in the CKD Stage 3-5 group. The corresponding OR s for high stroke risk were 1.9 (P < 0.001) and 8.2 (P < 0.001), respectively.
Conclusion: In patients with T2DM, advanced CKD stage was associated with the increased risks of CHD and stroke.
Conflict of interest statement
There are no conflicts of interest.
Figures


Similar articles
-
Subclinical hypothyroidism and the associations with macrovascular complications and chronic kidney disease in patients with Type 2 diabetes.Diabet Med. 2015 Aug;32(8):1097-103. doi: 10.1111/dme.12724. Epub 2015 Feb 26. Diabet Med. 2015. PMID: 25683250
-
Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality.Acta Diabetol. 2012 Dec;49 Suppl 1:S65-71. doi: 10.1007/s00592-010-0205-5. Epub 2010 Jul 1. Acta Diabetol. 2012. PMID: 20593206
-
[The prevalence and risk factors of coronary heart disease combined with chronic kidney disease].Zhonghua Nei Ke Za Zhi. 2012 Feb;51(2):123-6. Zhonghua Nei Ke Za Zhi. 2012. PMID: 22490813 Chinese.
-
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.Nat Rev Nephrol. 2016 Feb;12(2):73-81. doi: 10.1038/nrneph.2015.173. Epub 2015 Nov 10. Nat Rev Nephrol. 2016. PMID: 26553517 Review.
-
Heart Disease and the Kidneys.Contrib Nephrol. 2021;199:71-79. doi: 10.1159/000517704. Epub 2021 Aug 24. Contrib Nephrol. 2021. PMID: 34428764 Review.
Cited by
-
Association of retinol binding protein-4, cystatin C, homocysteine and high-sensitivity C-reactive protein levels in patients with newly diagnosed type 2 diabetes mellitus.Arch Med Sci. 2019 Sep;15(5):1203-1216. doi: 10.5114/aoms.2018.79565. Epub 2018 Nov 13. Arch Med Sci. 2019. PMID: 31572465 Free PMC article.
-
Risk factors of chronic kidney diseases in Chinese adults with type 2 diabetes.Sci Rep. 2018 Oct 2;8(1):14686. doi: 10.1038/s41598-018-32983-1. Sci Rep. 2018. PMID: 30279452 Free PMC article.
-
Type 2 Diabetes Mellitus and Macrovascular Complications.Int J Endocrinol. 2017;2017:4301461. doi: 10.1155/2017/4301461. Epub 2017 Oct 31. Int J Endocrinol. 2017. PMID: 29230243 Free PMC article. No abstract available.
-
Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease.Cardiovasc Diabetol. 2021 Mar 1;20(1):58. doi: 10.1186/s12933-021-01247-0. Cardiovasc Diabetol. 2021. PMID: 33648518 Free PMC article.
-
Gender-Disparities in the in-Hospital Clinical Outcome Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention.Int J Gen Med. 2022 Jan 14;15:593-602. doi: 10.2147/IJGM.S343129. eCollection 2022. Int J Gen Med. 2022. PMID: 35058710 Free PMC article.
References
-
- Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 1999;354:617–21. doi: 10.1016/S0140-6736(98)12131-1. - PubMed
-
- Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care. 2002;25:1129–34. doi: 10.2337/diacare.25.7.1129. - PubMed
-
- Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, et al. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–22. doi: 10.1016/S0140-6736(10)60484-9. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous